Knockdown of IER3 Promotes Osteogenic Differentiation of Human Mesenchymal Stem Cells
Biomedicines,
Journal Year:
2025,
Volume and Issue:
13(4), P. 947 - 947
Published: April 12, 2025
Background:
The
differentiation
process
of
human
mesenchymal
stem
cells
(hMSCs)
is
regulated
by
a
variety
chemical,
physical,
and
biological
factors.
These
factors
activate
distinct
signaling
pathways
transcriptional
networks,
thereby
regulating
the
lineage-specific
hMSCs.
Objective:
This
study
aims
to
investigate
role
Immediate
Early
Response
3
(IER3)
in
osteogenic
explore
underlying
regulatory
mechanisms
which
IER3
influences
osteogenesis.
Methods:
expression
levels
osteogenesis-related
genes
were
quantified
when
hMSCs
subjected
vitro
induction.
Then,
stable
IER3–knockdown
generated
using
IER3–targeted
shRNA
lentiviral
vectors,
impact
on
was
evaluated
through
both
cell
induction
subcutaneous
implantation
model
nude
mice.
Moreover,
RNA–seq
functional
inhibition
assays
performed
elucidate
pathway
regulates
Results:
significantly
downregulated
during
differentiation.
Knockdown
markedly
upregulated
ALP
RUNX2,
enhancing
capacity
hMSCs,
vivo.
Mechanistic
studies
revealed
that
knockdown
increased
phosphorylated
ERK1/2
levels,
activating
MAPK/ERK
pathway.
Furthermore,
reversed
enhanced
observed
following
knockdown.
Conclusions:
promotes
regulation
pathway,
indicating
represents
potential
therapeutic
target
for
treatment
osteoporosis
bone
defect-related
diseases.
Language: Английский
Exosomes Extracted from Human Umbilical Cord MSCs Contribute to Osteoarthritic Cartilage and Chondrocytes Repair Through Enhancing Autophagy While Suppressing the Wnt/β-Catenin Pathway
Tissue Engineering and Regenerative Medicine,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 15, 2025
Language: Английский
Therapeutic Potential of Exosomal miRNAs: New Insights and Future Directions
Haohong Duan,
No information about this author
Seyedeh Helya Siadat,
No information about this author
Saade Abdalkareem Jasim
No information about this author
et al.
Journal of Biochemical and Molecular Toxicology,
Journal Year:
2025,
Volume and Issue:
39(5)
Published: April 24, 2025
ABSTRACT
Modern
advancements
in
medicine
include
developing
targeted
drug
delivery
systems
the
medical
field,
which
are
designed
to
unravel
potential
of
therapeutic
products
and
overcome
barriers
effectiveness
current
approaches.
Various
nanopolymer
carrier
have
been
introduced
this
regard,
simple
characteristics
extracellular
vesicles
drawn
special
attention
their
application
as
an
effective
tool.
Exosomes
very
similar
transport
a
lipid‐biomembrane
covering
aqueous
core.
They
also
contain
both
hydrophilic
lipophilic
substances
deliver
cargo
desired
targets.
These
properties
enable
exosomes
some
limitations
liposomes.
can
easily
diffuse
into
body
fluids
remain
bloodstream
for
long
time,
crossing
physiological
entering
cells.
Exosomes,
large
volume
biomolecules,
do
not
stimulate
immune
responses
accumulate
liver
or
lungs
instead
target
tissues.
Recent
regenerative
enabled
scientists
utilize
extracted
from
mesenchymal
stem
cells
(MSCs),
possess
significant
abilities,
treating
various
diseases.
The
contents
these
crucial
diagnosis
treatment,
they
influence
disease
progression.
Numerous
vitro
studies
confirmed
safety,
effectiveness,
promise
conditions
such
cancer,
neurodegenerative
disorders,
cardiovascular
issues,
orthopedic
ailments.
This
article
explores
MSC‐derived
outlines
essential
procedures
preparation.
Language: Английский